File
DOJ
Document DOJ-OGR-00024124
AI Analysis
Summary: On July 12, 2019, Jeffrey Epstein requested a change in his constipation medication from Bisacodyl to Docusate Sodium (Colace). The change was approved and processed by a medical provider at the Metropolitan Correctional Center in New York (NYM).
Significance: This document provides insight into Jeffrey Epstein's medical treatment while incarcerated, specifically a change in his medication for constipation.
Key Topics:
Jeffrey Epstein's medical treatment
Medication change for constipation
Bureau of Prisons Health Services
Key People:
- Jeffrey Epstein - Inmate receiving medical treatment
- (b)(6) (b)(7)(C) MD - Provider/Prescriber of medication